top of page
Search
Summit Therapeutics – Ivonescimab in Non-Squamous NSCLC Clinical Trial and Beyond
Summit Therapeutics presents a buying opportunity in the long-term. Ivonescimab looks to change the cancer care landscape.
May 15 min read
Celcuity - Gedatolisib Phase 3 Results
Celcuity gedatolisib phase 3 analysis for breast cancer
Apr 157 min read
bottom of page